Current Concepts in Mild Cognitive Impairment

“Mini-mental state”

Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975) · Journal of Psychiatric Research · doi:10.1016/0022-3956(75)90026-6 · Cited by 88,282

The Clinical Dementia Rating (CDR): Current version and scoring rules

Morris, J. C. (1993) · Neurology · doi:10.1212/wnl.43.11.2412-a · Cited by 9,882

Mild Cognitive Impairment: Clinical Characterization and Outcome

Petersen, R. C., Smith, G. E., Waring, S. C., Ivnik, R. J., Tangalos, E. G., & Kokmen, E. (1999) · Archives of Neurology · doi:10.1001/archneur.56.3.303 · Cited by 8,980

A new rating scale for Alzheimer's disease

(1984) · American Journal of Psychiatry · doi:10.1176/ajp.141.11.1356 · Cited by 4,175

β-Secretase Cleavage of Alzheimer's Amyloid Precursor Protein by the Transmembrane Aspartic Protease BACE

Vassar, R., Bennett, B. D., Babu-Khan, S., Kahn, S., Mendiaz, E. A., Denis, P., Teplow, D. B., Ross, S., Amarante, P., Loeloff, R., et al. (1999) · Science · doi:10.1126/science.286.5440.735 · Cited by 3,876 · cited 1×

Immunization with amyloid-β attenuates Alzheimer-disease-like pathology in the PDAPP mouse

Schenk, D., Barbour, R., Dunn, W., Gordon, G., Grajeda, H., Guido, T., Hu, K., Huang, J., Johnson-Wood, K., Khan, K., et al. (1999) · Nature · doi:10.1038/22124 · Cited by 3,160

A Controlled Trial of Selegiline, Alpha-Tocopherol, or Both as Treatment for Alzheimer's Disease

Sano, M., Ernesto, C., Thomas, R. G., Klauber, M. R., Schafer, K., Grundman, M., Woodbury, P., Growdon, J., Cotman, C. W., Pfeiffer, E., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199704243361704 · Cited by 2,380

Practice parameter: Early detection of dementia: Mild cognitive impairment (an evidence-based review) [RETIRED]: Report of the Quality Standards Subcommittee of the American Academy of Neurology

Petersen, R. C., Stevens, J. C., Ganguli, M., Tangalos, E. G., Cummings, J. L., & DeKosky, S. T. (2001) · Neurology · doi:10.1212/wnl.56.9.1133 · Cited by 2,065

Prediction of AD with MRI-based hippocampal volume in mild cognitive impairment

Jack, C. R., Petersen, R. C., Xu, Y. C., O’Brien, P. C., Smith, G. E., Ivnik, R. J., Boeve, B. F., Waring, S. C., Tangalos, E. G., & Kokmen, E. (1999) · Neurology · doi:10.1212/wnl.52.7.1397 · Cited by 1,404

Preclinical Evidence of Alzheimer's Disease in Persons Homozygous for the ε4 Allele for Apolipoprotein E

Reiman, E. M., Caselli, R. J., Yun, L. S., Chen, K., Bandy, D., Minoshima, S., Thibodeau, S. N., & Osborne, D. (1996) · New England Journal of Medicine · doi:10.1056/nejm199603213341202 · Cited by 1,366

Can a virtual reality cognitive training application fulfill a dual role? Using the virtual supermarket cognitive training application as a screening tool for mild cognitive impairment

Zygouris, S., Giakoumis, D., Votis, K., Doumpoulakis, S., Ntovas, K., Segkouli, S., Karagiannidis, C., Tzovaras, D., & Tsolaki, M. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-141260 · Cited by 158

Genome-wide association with MRI atrophy measures as a quantitative trait locus for Alzheimer’s disease

Furney, S. J., Simmons, A., Breen, G., Pedroso, I., Lunnon, K., Proitsi, P., Hodges, A., Powell, J., Wahlund, L.-O., Kloszewska, I., et al. (2011) · Molecular Psychiatry · doi:10.1038/mp.2010.123 · Cited by 157

FDG-PET as an independent biomarker for Alzheimer’s biological diagnosis: A longitudinal study

Initiative, O. B. O. A. D. N., Ou, Y.-N., Xu, W., Li, J.-Q., Guo, Y., Cui, M., Chen, K.-L., Huang, Y.-Y., Dong, Q., Tan, L., et al. (2019) · Alzheimer's Research & Therapy · doi:10.1186/s13195-019-0512-1 · Cited by 155

Heterogeneity in mild cognitive impairment: Differences in neuropsychological profile and associated white matter lesion pathology

DELANO-WOOD, L., BONDI, M. W., SACCO, J., ABELES, N., JAK, A. J., LIBON, D. J., & BOZOKI, A. (2009) · Journal of the International Neuropsychological Society · doi:10.1017/s1355617709990257 · Cited by 155

Grey and white matter changes at different stages of Alzheimer’s disease

Serra, L., Cercignani, M., Lenzi, D., Perri, R., Fadda, L., Caltagirone, C., Macaluso, E., & Bozzali, M. (2010) · Journal of Alzheimer's Disease · doi:10.3233/jad-2010-1223 · Cited by 149

Disruption of cerebral networks and cognitive impairment in Alzheimer disease.

Reijmer, Y. D., Leemans, A., Caeyenberghs, K., Heringa, S. M., Koek, H. L., Biessels, G. J., & On behalf of the Utrecht Vascular Cognitive Impairment Study Group (2013) · Neurology · doi:10.1212/wnl.0b013e31828c2ee5 · Cited by 147

Trajectories of brain loss in aging and the development of cognitive impairment

Carlson, N. E., Moore, M. M., Dame, A., Howieson, D., Silbert, L. C., Quinn, J. F., & Kaye, J. A. (2008) · Neurology · doi:10.1212/01.wnl.0000280577.43413.d9 · Cited by 144

Diagnostic utility of hippocampal size and mean diffusivity in amnestic MCI.

Müller, M. J., Greverus, D., Weibrich, C., Dellani, P. R., Scheurich, A., Stoeter, P., & Fellgiebel, A. (2007) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2006.01.009 · Cited by 140

The Role of Neuroinflammation in Dementias

Pasqualetti, G., Brooks, D. J., & Edison, P. (2015) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-015-0531-7 · Cited by 133

Use of the Virtual Action Planning Supermarket for the Diagnosis of Mild Cognitive Impairment

Werner, P., Rabinowitz, S., Klinger, E., Korczyn, A. D., & Josman, N. (2009) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000204915 · Cited by 135

Parenchymal and vascular Aβ‐deposition and its effects on the degeneration of neurons and cognition in Alzheimer's disease

Thal, D. R., Griffin, W. S. T., & Braak, H. (2008) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2008.00411.x · Cited by 134

New MRI markers for Alzheimer’s disease: a meta-analysis of diffusion tensor imaging and a comparison with medial temporal lobe measurements

Clerx, L., Visser, P. J., Verhey, F., & Aalten, P. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2011-110797 · Cited by 132

Smoking History and Cognitive Function in Middle Age From the Whitehall II Study

Sabia, S. (2008) · Archives of Internal Medicine · doi:10.1001/archinte.168.11.1165 · Cited by 128

The heterogeneity of mild cognitive impairment: A neuropsychological analysis

LIBON, D. J., XIE, S. X., EPPIG, J., WICAS, G., LAMAR, M., LIPPA, C., BETTCHER, B. M., PRICE, C. C., GIOVANNETTI, T., SWENSON, R., et al. (2010) · Journal of the International Neuropsychological Society · doi:10.1017/s1355617709990993 · Cited by 130

Decline in verbal memory during preclinical Alzheimer's disease: Examination of the effect of APOE genotype

LANGE, K. L., BONDI, M. W., SALMON, D. P., GALASKO, D., DELIS, D. C., THOMAS, R. G., & THAL, L. J. (2002) · Journal of the International Neuropsychological Society · doi:10.1017/s1355617702870096 · Cited by 129

Mild cognitive impairment: coping with an uncertain label

Joosten‐Weyn Banningh, L., Vernooij‐Dassen, M., Rikkert, M. O., & Teunisse, J. (2008) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.1855 · Cited by 127

Dynamic 11 C-PiB PET Shows Cerebrospinal Fluid Flow Alterations in Alzheimer Disease and Multiple Sclerosis

Schubert, J. J., Veronese, M., Marchitelli, L., Bodini, B., Tonietto, M., Stankoff, B., Brooks, D. J., Bertoldo, A., Edison, P., & Turkheimer, F. E. (2019) · Journal of Nuclear Medicine · doi:10.2967/jnumed.118.223834 · Cited by 121

Circulating Biomarkers of Cognitive Decline and Dementia

Solfrizzi, V., D'Introno, A., Colacicco, A. M., Capurso, C., Todarello, O., Pellicani, V., Capurso, S. A., Pietrarossa, G., Santamato, V., Capurso, A., et al. (2006) · Clinica Chimica Acta · doi:10.1016/j.cca.2005.06.015 · Cited by 120

Fornix as an imaging marker for episodic memory deficits in healthy aging and in various neurological disorders

Douet, V., & Chang, L. (2015) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2014.00343 · Cited by 122

Multiple indices of diffusion identifies white matter damage in mild cognitive impairment and Alzheimer’s disease

O'Dwyer, L., Lamberton, F., Bokde, A. L. W., Ewers, M., Faluyi, Y. O., Tanner, C., Mazoyer, B., O'Neill, D., Bartley, M., Collins, D. R., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0021745 · Cited by 119

Metabolomic profiling of serum in the progression of Alzheimer's disease by capillary electrophoresis–mass spectrometry

González‐Domínguez, R., García, A., García‐Barrera, T., Barbas, C., & Gómez‐Ariza, J. L. (2014) · ELECTROPHORESIS · doi:10.1002/elps.201400196 · Cited by 119

Normal rates of cognitive change in successful aging: The Freedom House Study

ROYALL, D. R., PALMER, R., CHIODO, L. K., & POLK, M. J. (2005) · Journal of the International Neuropsychological Society · doi:10.1017/s135561770505109x · Cited by 118

Increased CSF-BACE 1 activity is associated with ApoE-ε4 genotype in subjects with mild cognitive impairment and Alzheimer's disease

Ewers, M., Zhong, Z., Bürger, K., Wallin, A., Blennow, K., Teipel, S. J., Shen, Y., & Hampel, H. (2008) · Brain · doi:10.1093/brain/awn034 · Cited by 119

Aerobic exercises for cognition rehabilitation following stroke: a systematic review

Zheng, G., Zhou, W., Xia, R., Tao, J., & Chen, L. (2016) · Journal of Stroke and Cerebrovascular Diseases · doi:10.1016/j.jstrokecerebrovasdis.2016.07.035 · Cited by 111

Using support vector machines with multiple indices of diffusion for automated classification of mild cognitive impairment

O'Dwyer, L., Lamberton, F., Bokde, A. L. W., Ewers, M., Faluyi, Y. O., Tanner, C., Mazoyer, B., O'Neill, D., Bartley, M., Collins, D. R., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0032441 · Cited by 117

A Double-Blind, Placebo-Controlled, Ascending-Dose, Randomized Study to Evaluate the Safety, Tolerability and Effects on Cognition of AL-108 after 12 Weeks of Intranasal Administration in Subjects with Mild Cognitive Impairment

Morimoto, B. H., Schmechel, D., Hirman, J., Blackwell, A., Keith, J., Gold, M., & on behalf of the AL-108-211 Study Investigators (2013) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000348347 · Cited by 115

Alzheimer's disease including focal presentations

Villain, N., & Dubois, B. (2019) · Seminars in Neurology · doi:10.1055/s-0039-1681041 · Cited by 113

The fornix and mammillary bodies in older adults with Alzheimer’s disease, mild cognitive impairment, and cognitive complaints: A volumetric MRI study.

Copenhaver, B. R., Rabin, L. A., Saykin, A. J., Roth, R. M., Wishart, H. A., Flashman, L. A., Santulli, R. B., McHugh, T. L., & Mamourian, A. C. (2006) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2006.01.015 · Cited by 112

Memory complaints and risk of cognitive impairment after nearly 2 decades among older women

Kaup, A. R., Nettiksimmons, J., LeBlanc, E. S., & Yaffe, K. (2015) · Neurology · doi:10.1212/wnl.0000000000002153 · Cited by 109

Discriminative and predictive power of an informant report in mild cognitive impairment

Isella, V (2006) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2005.069765 · Cited by 109

MEMO+: Efficacy, Durability and Effect of Cognitive Training and Psychosocial Intervention in Individuals with Mild Cognitive Impairment

Belleville, S., Hudon, C., Bier, N., Brodeur, C., Gilbert, B., Grenier, S., Ouellet, M., Viscogliosi, C., & Gauthier, S. (2018) · Journal of the American Geriatrics Society · doi:10.1111/jgs.15192 · Cited by 109

Damage to the cingulum contributes to Alzheimer’s disease pathophysiology by deafferentation mechanism

Bozzali, M., Giulietti, G., Basile, B., Serra, L., Spanò, B., Perri, R., Giubilei, F., Marra, C., Caltagirone, C., & Cercignani, M. (2012) · Human Brain Mapping · doi:10.1002/hbm.21287 · Cited by 107

A Combination of Green Tea Extract and l -Theanine Improves Memory and Attention in Subjects with Mild Cognitive Impairment: A Double-Blind Placebo-Controlled Study

Park, S.-K., Jung, I.-C., Lee, W. K., Lee, Y. S., Park, H. K., Go, H. J., Kim, K., Lim, N. K., Hong, J. T., Ly, S. Y., et al. (2011) · Journal of Medicinal Food · doi:10.1089/jmf.2009.1374 · Cited by 105

Artificial intelligence and neuropsychological measures: the case of Alzheimer's disease

Battista, P., Salvatore, C., Berlingeri, M., Cerasa, A., & Castiglioni, I. (2020) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2020.04.026 · Cited by 98

Wnt/β-Catenin Signaling in Alzheimer’s Disease

Ferrari, G., Avila, M., Medina, M., Perez-Palma, E., Bustos, B., & Alarcon, M. (2014) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527312666131223113900 · Cited by 95

Carotid Intima-Media Thickness and Cognitive Function in Elderly Women: A Population-Based Study

Komulainen, P., Kivipelto, M., Lakka, T. A., Hassinen, M., Helkala, E.-L., Patja, K., Nissinen, A., & Rauramaa, R. (2007) · Neuroepidemiology · doi:10.1159/000108112 · Cited by 98

Molecular imaging of neuroinflammation in Alzheimer's disease and mild cognitive impairment

Knezevic, D., & Mizrahi, R. (2018) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2017.05.007 · Cited by 97

Folate, vitamin B-6, and vitamin B-12 intake and mild cognitive impairment and probable dementia in the Women’s Health Initiative Memory Study

Agnew-Blais, J. C., Wassertheil-Smoller, S., Kang, J. H., Hogan, P. E., Coker, L. H., Snetselaar, L. G., & Smoller, J. W. (2015) · Journal of the Academy of Nutrition and Dietetics · doi:10.1016/j.jand.2014.07.006 · Cited by 95

Episodic future thinking in amnesic mild cognitive impairment

Gamboz, N., De Vito, S., Brandimonte, M. A., Pappalardo, S., Galeone, F., Iavarone, A., & Sala, S. D. (2010) · Neuropsychologia · doi:10.1016/j.neuropsychologia.2010.03.030 · Cited by 95

Sustainable method for Alzheimer dementia prediction in mild cognitive impairment: Electroencephalographic connectivity and graph theory combined with apolipoprotein E

Vecchio, F., Miraglia, F., Iberite, F., Lacidogna, G., Guglielmi, V., Marra, C., Pasqualetti, P., Tiziano, F. D., & Rossini, P. M. (2018) · Annals of Neurology · doi:10.1002/ana.25289 · Cited by 89

Effects of folic acid supplementation on cognitive function and Aβ-related biomarkers in mild cognitive impairment: a randomized controlled trial

Ma, F., Li, Q., Zhou, X., Zhao, J., Song, A., Li, W., Liu, H., Xu, W., & Huang, G. (2019) · European Journal of Nutrition · doi:10.1007/s00394-017-1598-5 · Cited by 90

Gut microbiota interacts with intrinsic brain activity of patients with amnestic mild cognitive impairment

Liu, P., Jia, X., Chen, Y., Yu, Y., Zhang, K., Lin, Y., Wang, B., & Peng, G. (2021) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.13451 · Cited by 87

Predictors of reversible mild cognitive impairment after stroke: a 2-year follow-up study

Rasquin, S. M. C., Lodder, J., & Verhey, F. R. J. (2005) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2004.11.015 · Cited by 82

Predictive Value of Mild Cognitive Impairment for Dementia

Baars, M. A. E., van Boxtel, M. P. J., Dijkstra, J. B., Visser, P. J., van den Akker, M., Verhey, F. R. J., & Jolles, J. (2009) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000200465 · Cited by 87

Quantitative magnetic resonance techniques as surrogate markers of Alzheimer’s disease

Kantarci, K., & Jack, C. R. (2004) · NeuroRX · doi:10.1602/neurorx.1.2.196 · Cited by 80

Functional, Global and Cognitive Decline Correlates to Accumulation of Alzheimers Pathology in MCI and AD

Sabbagh, M. N., Cooper, K., DeLange, J., Stoehr, J. D., Thind, K., Lahti, T., Reisberg, B., Sue, L., Vedders, L., Fleming, S. R., et al. (2010) · Current Alzheimer Research · doi:10.2174/156720510791162340 · Cited by 79

Functional MRI Assessment of Task-Induced Deactivation of the Default Mode Network in Alzheimer’s Disease and At-Risk Older Individuals

Pihlajamäki, M., & Sperling, R. A. (2009) · Behavioural Neurology · doi:10.1155/2009/276384 · Cited by 102

Neuroimaging in Parkinson’s disease dementia: connecting the dots

Weil, R. S., Hsu, J. K., Darby, R. R., Soussand, L., & Fox, M. D. (2019) · Brain Communications · doi:10.1093/braincomms/fcz006 · Cited by 71

Phospholipase A2 activation as a therapeutic approach for cognitive enhancement in early-stage Alzheimer disease

Schaeffer, E. L., Forlenza, O. V., & Gattaz, W. F. (2009) · Psychopharmacology · doi:10.1007/s00213-008-1351-0 · Cited by 71

Preclinical AD Workgroup staging: Pathological correlates and potential challenges

Jicha, G. A., Abner, E. L., Schmitt, F. A., Kryscio, R. J., Riley, K. P., Cooper, G. E., Stiles, N., Mendiondo, M. S., Smith, C. D., Van Eldik, L. J., et al. (2012) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2011.02.018 · Cited by 71

Diffusion MRI biomarkers of white matter microstructure vary nonmonotonically with increasing cerebral amyloid deposition

Dong, J. W., Jelescu, I. O., Ades-Aron, B., Novikov, D. S., Friedman, K., Babb, J. S., Osorio, R. S., Galvin, J. E., Shepherd, T. M., & Fieremans, E. (2020) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2020.01.009 · Cited by 70

Impact of Antidiabetic Medications on Physical and Cognitive Functioning of Older Mexican Americans with Diabetes Mellitus

Wu, J. H., Haan, M. N., Liang, J., Ghosh, D., Gonzalez, H. M., & Herman, W. H. (2003) · Annals of Epidemiology · doi:10.1016/s1047-2797(02)00464-7 · Cited by 68

Cognitive training in older adults with Mild Cognitive Impairment: Impact on cognitive and functional performance

Brum, P. S., Forlenza, O. V., & Yassuda, M. S. (2009) · Dementia & Neuropsychologia · doi:10.1590/s1980-57642009dn30200010 · Cited by 67

Measuring cognitive change in subjects with prodromal Alzheimer’s disease

Mura, T., Proust-Lima, C., Jacqmin-Gadda, H., Akbaraly, T. N., Touchon, J., Dubois, B., & Berr, C. (2014) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2013-305078 · Cited by 64

Dementia care frameworks and assistive technologies for their implementation: a review

Koumakis, L., Chatzaki, C., Kazantzaki, E., Maniadi, E., & Tsiknakis, M. (2019) · IEEE Reviews in Biomedical Engineering · doi:10.1109/rbme.2019.2892614 · Cited by 64

Does inflammation precede tau aggregation in early Alzheimer's disease? A PET study

Parbo, P., Ismail, R., Sommerauer, M., Stokholm, M. G., Hansen, A. K., Hansen, K. V., Amidi, A., Schaldemose, J. L., Gottrup, H., Brændgaard, H., et al. (2018) · Neurobiology of Disease · doi:10.1016/j.nbd.2018.06.004 · Cited by 63

The prevalence of obstructive sleep apnea in mild cognitive impairment: a systematic review

Mubashir, T., Abrahamyan, L., Niazi, A., Piyasena, D., Arif, A. A., Wong, J., Osorio, R. S., Ryan, C. M., & Chung, F. (2019) · BMC Neurology · doi:10.1186/s12883-019-1422-3 · Cited by 65

Neurochemical and Neuroanatomical Plasticity Following Memory Training and Yoga Interventions in Older Adults with Mild Cognitive Impairment

Yang, H., Leaver, A. M., Siddarth, P., Paholpak, P., Ercoli, L., St. Cyr, N. M., Eyre, H. A., Narr, K. L., Khalsa, D. S., & Lavretsky, H. (2016) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2016.00277 · Cited by 61

Dilemmas in the (un)veiling of the diagnosis of Alzheimer's disease: Walking an ethical and professional tight rope

Karnieli-Miller, O., Werner, P., Aharon-Peretz, J., & Eidelman, S. (2007) · Patient Education and Counseling · doi:10.1016/j.pec.2007.03.014 · Cited by 61

The Oral Microbiome and Inflammation in Mild Cognitive Impairment

Yang, I., Arthur, R. A., Zhao, L., Clark, J., Hu, Y., Corwin, E. J., & Lah, J. (2021) · Experimental Gerontology · doi:10.1016/j.exger.2021.111273 · Cited by 56

Ecological Effects of VR-Based Cognitive Training on ADL and IADL in MCI and AD patients: A Systematic Review and Meta-Analysis

Son, C., & Park, J.-H. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph192315875 · Cited by 51

Psychometric properties of the Brazilian version of Pfeffer's Functional Activities Questionnaire

Assis, L. D. O., de Paula, J. J., Assis, M. G., de Moraes, E. N., & Malloy-Diniz, L. F. (2014) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2014.00255 · Cited by 54

Telomere shortening reflecting physical aging is associated with cognitive decline and dementia conversion in mild cognitive impairment due to Alzheimer’s disease

Koh, S.-H., Choi, S. H., Jeong, J. H., Jang, J.-W., Park, K. W., Kim, E.-J., Kim, H. J., Hong, J. Y., Yoon, S. J., Yoon, B., et al. (2020) · Aging · doi:10.18632/aging.102893 · Cited by 51

Subtyping of mild cognitive impairment using a deep learning model based on brain atrophy patterns

Kwak, K., Giovanello, K. S., Bozoki, A., Styner, M., & Dayan, E. (2021) · Cell Reports Medicine · doi:10.1016/j.xcrm.2021.100467 · Cited by 47

Lymphocytic mitochondrial aconitase activity is reduced in Alzheimer’s disease and mild cognitive impairment

Mangialasche, F., Baglioni, M., Cecchetti, R., Kivipelto, M., Ruggiero, C., Piobbico, D., Kussmaul, L., Monastero, R., Brancorsini, S., & Mecocci, P. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-142052 · Cited by 53

A cognitive behavioural group therapy for patients diagnosed with mild cognitive impairment and their significant others: feasibility and preliminary results

Joosten-Weyn Banningh, L. W., Kessels, R. P., Olde Rikkert, M. G., Geleijns-Lanting, C. E., & Kraaimaat, F. W. (2008) · Clinical Rehabilitation · doi:10.1177/0269215508090774 · Cited by 53

In Search of Sleep Biomarkers of Alzheimer’s Disease: K-Complexes Do Not Discriminate between Patients with Mild Cognitive Impairment and Healthy Controls

Reda, F., Gorgoni, M., Lauri, G., Truglia, I., Cordone, S., Scarpelli, S., Mangiaruga, A., D'Atri, A., Ferrara, M., Lacidogna, G., et al. (2017) · Brain Sciences · doi:10.3390/brainsci7050051 · Cited by 52

The influence of cerebral small vessel disease on default mode network deactivation in mild cognitive impairment

Papma, J. M., den Heijer, T., de Koning, I., Mattace-Raso, F. U., van der Lugt, A., van der Lijn, F., van Swieten, J. C., Koudstaal, P. J., Smits, M., & Prins, N. D. (2013) · NeuroImage: Clinical · doi:10.1016/j.nicl.2012.11.005 · Cited by 48

Utility of the LIBRA Index in Relation to Cognitive Functioning in a Clinical Health Seeking Sample

Pons, A., LaMonica, H. M., Mowszowski, L., Köhler, S., Deckers, K., & Naismith, S. L. (2018) · Journal of Alzheimer’s Disease · doi:10.3233/jad-170731 · Cited by 45

Multimodal Hippocampal Subfield Grading For Alzheimer’s Disease Classification

Hett, K., Ta, V.-T., Catheline, G., Tourdias, T., Manjón, J. V., Coupé, P., Initiative, A. D. N., Weiner, M. W., Aisen, P., Petersen, R., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-49970-9 · Cited by 49

CSF Aβ42, Tau and Phosphorylated Tau Correlate with Medial Temporal Lobe Atrophy

Herukka, S.-K., Pennanen, C., Soininen, H., & Pirttilä, T. (2008) · Journal of Alzheimer's Disease · doi:10.3233/jad-2008-14105 · Cited by 47

Prediction of fast decline in amyloid positive mild cognitive impairment patients using multimodal biomarkers

Jang, H., Park, J., Woo, S., Kim, S., Kim, H. J., Na, D. L., Lockhart, S. N., Kim, Y., Kim, K. W., Cho, S. H., et al. (2019) · NeuroImage Clinical · doi:10.1016/j.nicl.2019.101941 · Cited by 46

The I.F.A.S.T. Model Allows the Prediction of Conversion to Alzheimer Disease in Patients with Mild Cognitive Impairment with High Degree of Accuracy

Buscema, M., Grossi, E., Capriotti, M., Babiloni, C., & Rossini, P. (2010) · Current Alzheimer Research · doi:10.2174/156720510790691137 · Cited by 46

APOE interacts with age to modify rate of decline in cognitive and brain changes in Alzheimer's disease

Chang, Y., Fennema‐Notestine, C., Holland, D., McEvoy, L. K., Stricker, N. H., Salmon, D. P., Dale, A. M., Bondi, M. W., & Initiative, A. D. N. (2014) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2013.05.1763 · Cited by 39

Patterns of neuropsychological impairment in MCI patients with small subcortical infarcts or hippocampal atrophy

GAINOTTI, G., FERRACCIOLI, M., VITA, M. G., & MARRA, C. (2008) · Journal of the International Neuropsychological Society · doi:10.1017/s1355617708080831 · Cited by 39

Prevalence estimates of major neurocognitive disorders in a rural Nigerian community

Ogunniyi, A., Adebiyi, A. O., Adediran, A. B., Olakehinde, O. O., & Siwoku, A. A. (2016) · Brain and Behavior · doi:10.1002/brb3.481 · Cited by 40

Plasma Homocysteine and Risk of Mild Cognitive Impairment

Reitz, C., Tang, M.-X., Miller, J., Green, R., & Luchsinger, J. A. (2009) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000182421 · Cited by 38

Operationalizing mild cognitive impairment criteria in small vessel disease: the VMCI‐Tuscany Study

Salvadori, E., Poggesi, A., Valenti, R., Pracucci, G., Pescini, F., Pasi, M., Nannucci, S., Marini, S., Del Bene, A., Ciolli, L., et al. (2016) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2015.02.010 · Cited by 36

Mindfulness and psychoeducation to manage stress in amnestic mild cognitive impairment: A pilot study

Chouinard, A.-M., Larouche, E., Audet, M.-C., Hudon, C., & Goulet, S. (2019) · Aging & Mental Health · doi:10.1080/13607863.2018.1484890 · Cited by 35

T1rho MRI and CSF biomarkers in diagnosis of Alzheimer's disease

Haris, M., Yadav, S. K., Rizwan, A., Singh, A., Cai, K., Kaura, D., Wang, E., Davatzikos, C., Trojanowski, J. Q., Melhem, E. R., et al. (2015) · NeuroImage: Clinical · doi:10.1016/j.nicl.2015.02.016 · Cited by 33

Two Blood Monocytic Biomarkers (CCL15 and p21) Combined with the Mini-Mental State Examination Discriminate Alzheimer’s Disease Patients from Healthy Subjects

Hochstrasser, T., Marksteiner, J., Defrancesco, M., Deisenhammer, E. A., Kemmler, G., & Humpel, C. (2011) · Dementia and Geriatric Cognitive Disorders Extra · doi:10.1159/000330468 · Cited by 31

Clinical and neuroimaging correlates of mild cognitive impairment in a middle-aged community sample: the personality and total health through life 60+ study

Kumar, R., Parslow, R. A., Jorm, A. F., Rosenman, S. J., Maller, J., Meslin, C., Anstey, K. J., Christensen, H., & Sachdev, P. S. (2006) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000089251 · Cited by 31

The effect of white matter signal abnormalities on default mode network connectivity in mild cognitive impairment

Wang, Z., Williams, V. J., Stephens, K. A., Kim, C., Bai, L., Zhang, M., & Salat, D. H. (2020) · Human Brain Mapping · doi:10.1002/hbm.24871 · Cited by 28

Measuring the impact of cognitive and psychosocial interventions in persons with mild cognitive impairment with a randomized single-blind controlled trial: rationale and design of the MEMO+ study

Bier, N., Grenier, S., Brodeur, C., Gauthier, S., Gilbert, B., Hudon, C., Lepage, É., Ouellet, M.-C., Viscogliosi, C., & Belleville, S. (2015) · International Psychogeriatrics · doi:10.1017/s1041610214001902 · Cited by 28

Biomarker-based signature of alzheimer's disease in pre-MCI individuals

Chipi, E., Salvadori, N., Farotti, L., & Parnetti, L. (2019) · Brain Sciences · doi:10.3390/brainsci9090213 · Cited by 27

Neurofibrillary changes of the Alzheimer type in very elderly individuals: Neither inevitable nor benign

Del Tredici, K., & Braak, H. (2008) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2008.04.016 · Cited by 27

The Use of the Clinical Dementia Rating Scale Sum of Boxes Scores in Detecting and Staging Cognitive Impairment/Dementia in Brazilian Patients With Low Educational Attainment

Lima, A. P. V., Castilhos, R., & Chaves, M. L. F. (2017) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0000000000000205 · Cited by 26

Diagnostic accuracy of CERAD total score in a Colombian cohort with mild cognitive impairment and Alzheimer's disease affected by E280A mutation on presenilin-1 gene

Aguirre-Acevedo, D. C., Jaimes-Barragán, F., Henao, E., Tirado, V., Muñoz, C., Reiman, E. M., Tariot, P. N., Langbaum, J. B., & Lopera, F. (2016) · International Psychogeriatrics · doi:10.1017/s1041610215001660 · Cited by 25

Preventing cognitive decline in preclinical Alzheimer's disease

Riedel, W. J. (2014) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2013.10.002 · Cited by 22

Relationship among diffusion tensor imaging, EEG activity, and cognitive status in mild cognitive impairment and Alzheimer’s disease patients

Scrascia, F., Curcio, G., Ursini, F., Trotta, L., Quintiliani, L., Migliore, S., Altamura, C., Pitocco, F., Altavilla, R., Melgari, J.-M., et al. (2013) · Journal of Alzheimer s Disease · doi:10.3233/jad-130788 · Cited by 22

Long-term effects of group therapy for patients with mild cognitive impairment and their significant others: A 6- to 8-month follow-up study

Banningh, L. W. A. J.-W., Roelofs, S. C. F., Vernooij-Dassen, M. J. F. J., Prins, J. B., Rikkert, M. G. M. O., & Kessels, R. P. C. (2013) · Dementia · doi:10.1177/1471301211420332 · Cited by 20

Altered mismatch response of inferior parietal lobule in amnestic mild cognitive impairment: A magnetoencephalographic study

Chen, P., Hsu, H., Chao, Y., Nouchi, R., Wang, P., & Cheng, C. (2021) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.13691 · Cited by 14

Comparison of conventional and actuarial neuropsychological criteria for mild cognitive impairment in a clinical setting

Fountain-Zaragoza, S., Braun, S. E., Horner, M. D., & Benitez, A. (2021) · Journal of Clinical and Experimental Neuropsychology · doi:10.1080/13803395.2021.2007857 · Cited by 12

Change in Depression, Confidence, and Physical Function Among Older Adults With Mild Cognitive Impairment

Ellis, J. L., Altenburger, P., & Lu, Y. (2019) · Journal of Geriatric Physical Therapy · doi:10.1519/jpt.0000000000000143 · Cited by 10

Predictors of Preclinical Alzheimer Disease and Dementia: A Clinicopathologic Study

Galvin, J. E., Powlishta, K. K., Wilkins, K., McKeel, D. W., Xiong, C., Grant, E., Storandt, M., & Morris, J. C. (2005) · Archives of Neurology · doi:10.1001/archneur.62.5.758 · Cited by 2

Effects of long-term blood pressure lowering and dual antiplatelet treatment on cognitive function in patients with recent lacunar stroke: a secondary analysis from the SPS3 randomised trial

Pearce, L. A., McClure, L. A., Anderson, D. C., Jacova, C., Sharma, M., Hart, R. G., & Benavente, O. R. (2014) · The Lancet Neurology · doi:10.1016/s1474-4422(14)70224-8 · Cited by 135